(2026). Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver. Molecular Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Colorectal Cancer‐derived FGF19 Is a Metabolically Active Serum Biomarker That Exerts Enteroendocrine Effects on Mouse Liver."
Molecular Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Colorectal Cancer‐derived FGF19 Is a Metabolically Active Serum Biomarker That Exerts Enteroendocrine Effects on Mouse Liver."
Molecular Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.